ÂÜÀòÂÒÂ×

Paul Escarpe has over 20 years of experience in the biotechnology industry. Prior to joining CHO Plus, he served as Senior Director of Cell Biology & Head of Therapeutics at Earli. Mr. Escarpe also served as Director of Vector & Cell Engineering at Stemcentrx, and has held scientific and leadership positions at Cell Genesys, VaxGen, and Gilead Sciences. His industrial expertise is focused on the engineering of mammalian cells and viral vectors for optimal protein expression. Mr. Escarpe received his B.S. and M.S. in Cell & Molecular Biology from San Francisco State University, and has co-authored over 15 peer-reviewed scientific publications, and several patents.